The Key We Are Overlooking in Peripheral Vascular Disease

To change the prognosis of peripheral vascular disease patients, a referral for supervised exercise is paramount. This should be a cultural change, not only an individual recommendation.

ejercicio y enfermedad vascular periférica

A physically active lifestyle reduces the risk of cardiovascular events and functional impairment in patients with peripheral vascular disease.

The novelty of this work (forthcoming in Eur J Vasc Endovasc Surg) is that it compares physical activity patterns from peripheral vascular disease patients in two countries: one presenting an epidemic of sedentary and overweight individuals (United Stated) and another that actively promotes physical activity as a public health policy (the Netherlands).

Patients self-reported their physical activity following a binary classification (sedentarism or physical activity), with follow-up at 3, 6, and 12 months.

Participants were registered in the Patient-centered Outcomes Related to Treatment Practices in Peripheral Arterial Disease: Investigating Trajectories (PORTRAIT) registry, which included patients with new or worsening intermittent claudication.

This study included a total of 1098 patients: 743 recruited in the US (67.7%) and 355 in the Netherlands (32.3%).


Read also: What Is the Healthiest Diet?


American patients were older (mean age: 68.6 years vs. 65.3 years; p < 0.001) and heavier (41.3% vs. 20.5%; p < 0.001), but fewer were smokers (30.1% vs. 52.8%; p < 0.001) and more were female (41.3% vs. 31.4%; p = 0.002).

The main difference between countries was the patients’ supervised exercise baseline (1.6% in the US vs. 63.9% in the Netherlands; p < 0.001). Not only were Americans more sedentary at baseline, but also only a small percentage of them were formally instructed to exercise in a supervised manner.

Conclusion

To change the prognosis of symptomatic peripheral vascular disease patients, a referral for supervised exercise is paramount. Advising them to walk moreis not enough: a cultural change must take place.

Original Title: Physical Activity in Patients with Symptomatic Peripheral Artery Disease: Insights from the PORTRAIT Registry.

Reference: Poghni A. Peri-Okonny et al. Eur J Vasc Endovasc Surg. 2020 Jul 21;S1078-5884(20)30528-1. https://doi.org/10.1016/j.ejvs.2020.06.010.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

AHA/ACC Guideline on the Management of Acute Pulmonary Embolism 2026

The 2026 ACC/AHA guideline for the management of acute pulmonary embolism (PE) introduces a conceptual shift by replacing the traditional “risk-based” classification with an...

FFR Assessment for the Selection of Hypertensive Patients Who Benefit from Renal Stenting

Atherosclerotic renal artery stenosis (ARAS) represents one of the main causes of secondary hypertension (HTN) and is associated with a higher risk of renal...

Transcatheter Deep Vein Arterialization in Critical Limb Ischemia Without Revascularization Options

Chronic limb-threatening ischemia in patients without conventional revascularization options represents one of the most challenging scenarios within peripheral arterial disease, with 1-year major amputation...

Duration of Smoking Cessation and Risk of Amputation After Revascularization in Critical Limb Ischemia

Critical limb ischemia (CLI) is associated with high rates of amputation and mortality. Although smoking cessation improves outcomes after revascularization, the impact of the...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Bioresorbable devices vs DES in patients at high risk of restenosis. Seven-year follow-up of the COMPARE-ABSORB trial

Studies with second-generation drug-eluting stents (DES) have shown that the rate of target lesion failure (TLF) increases linearly up to 5–10 years of follow-up,...

Low-Dose Rivaroxaban After Peripheral Angioplasty: Effectiveness and Safety in Real-World Clinical Practice

Following lower limb revascularization, optimal medical therapy includes antiplatelet agents, high-intensity statins, and control of cardiovascular risk factors. Recent studies such as COMPASS and...

Sheathless Femoral Impella: A New Strategy to Reduce Vascular Complications in High-Risk PCI?

Patients with complex coronary artery disease or cardiogenic shock undergoing percutaneous coronary intervention (PCI) may benefit from the hemodynamic support provided by percutaneous ventricular...